title: Bench-to-bench bottlenecks in translation.
abstract: Transfer of biopharmaceutical inventions between firms has bottlenecks in upstream development that suggest a role for repurposing mechanisms well before the clinical trials stage.
authors.affiliation: Scheller College of Business, Georgia Institute of Technology, Atlanta, GA 30308, USA. National Bureau of Economic Research, Cambridge, MA 02138, USA.
authors.forename: Matthew J
authors.initials: MJ
authors.lastname: Higgins
authors.affiliation: Scheller College of Business, Georgia Institute of Technology, Atlanta, GA 30308, USA.
authors.forename: Jerry
authors.initials: J
authors.lastname: Thursby
authors.affiliation: Scheller College of Business, Georgia Institute of Technology, Atlanta, GA 30308, USA. National Bureau of Economic Research, Cambridge, MA 02138, USA. marie.thursby@scheller.gatech.edu.
authors.forename: Marie
authors.initials: M
authors.lastname: Thursby
mesh_terms: D004194:Disease; D006801:Humans; D062068:Inventors; D057170:Translational Research, Biomedical